Delivery Order SPE2D021DA002-SPE2D324F9806

Award Date 5/16/24
Potential Completion Date 5/17/24
Potential Value $5.5K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,381.17 firm fixed-price contract is for the supply of ISENTRESS 400 MG tablets, and has a completion date of June 3, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,668.19, is for the delivery of ISENTRESS 400 MG TABLET and has a completion date of June 26, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,762.34 order is for ISENTRESS 400 MG TABLET, a pharmaceutical product, with a completion date of August 20, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,381.17, is for the delivery of ISENTRESS 400 MG TABLET to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,650.54 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of ISENTRESS 100 MG TABLET CHEW UU 60S, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The $2,541.64 order is to provide the pharmaceutical product ISENTRESS 400 MG TABLET. DMS Pharmaceutical Group holds various federal contracts and indefinite delivery vehicles (IDVs) with DLA to supply pharmaceuticals and medical products to military treatment facilities worldwide. This specific delivery order is part of a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,381.17, is for the delivery of ISENTRESS 400 MG TABLET to the Department of Defense (DoD) and Department of Veterans Affairs (VA). DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $6,905.85, is for the delivery of ISENTRESS 400 mg tablets. The contract has a period of performance through June 3, 2024 and uses a Firm Fixed Price pricing structure. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that provides a range of pharmaceutical products and medical supplies to the Department of Defense...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) under the DLA Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $24,861.06, is for the delivery of the pharmaceutical product Isentress 400 mg tablets. The contract has a firm fixed-price pricing type and a completion date of July 5, 2024. DMS Pharmaceutical Group Inc. holds a larger...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $2,762.34 order is for ISENTRESS 400 MG TABLET, a branded pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $4,999,999 that DMS Pharmaceutical Group holds with DLA for a broad range of pharmaceutical items to support...
  • SPE2D021DA002
    Indefinite Delivery Contract
  • SPE2D021DA002-SPE2D324F9806
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,524.68 firm fixed-price contract is for the delivery of ISENTRESS 400 MG TABLET, with a completion date of May 17, 2024.

DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, under the SPE2DB program. This vehicle allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The current delivery order is not associated with a set-aside program. Through this and other prime vendor contracts, DMS Pharmaceutical Group provides a vast array of medications, including both common and specialized pharmaceutical products, to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities.

Generated 8/15/24, 9:04 AM